The authors identified sortilin as a powerful biomarker associated with high blood pressure, since the increase in circulating sortilin levels (alongside sphingosine-1-phosphate [S1P] and soluble NADPH oxidase 2–derived [NOX2-derived] peptide) was more pronounced in uncontrolled hypertensive patients. The gene discussed is SORT1; the disease is hypertensive disorder.